Secondary peripheral T-cell lymphoma in a patient with DLBCL harboring <i>BLM</i> mutation following CD19/CD22 bispecific CAR-T cell therapy

Xindi Liu, Jia Cong, Xiayu Xia, Henan Wang, Xinjian Yu, Qinlong Zheng, Liang Wang

Open source

DOI
10.1136/jitc-2026-014873
Published
2026-07
Container
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2026-014873,
  title = {Secondary peripheral T-cell lymphoma in a patient with DLBCL harboring
                    <i>BLM</i>
                    mutation following CD19/CD22 bispecific CAR-T cell therapy},
  author = {Xindi Liu and Jia Cong and Xiayu Xia and Henan Wang and Xinjian Yu and Qinlong Zheng and Liang Wang},
  year = {2026},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2026-014873},
  url = {https://doi.org/10.1136/jitc-2026-014873}
}

RIS

TY  - JOUR
TI  - Secondary peripheral T-cell lymphoma in a patient with DLBCL harboring
                    <i>BLM</i>
                    mutation following CD19/CD22 bispecific CAR-T cell therapy
AU  - Xindi Liu
AU  - Jia Cong
AU  - Xiayu Xia
AU  - Henan Wang
AU  - Xinjian Yu
AU  - Qinlong Zheng
AU  - Liang Wang
PY  - 2026
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-014873
UR  - https://doi.org/10.1136/jitc-2026-014873
ER  - 

APA

Liu, X., Cong, J., Xia, X., Wang, H., Yu, X., Zheng, Q., & Wang, L. (2026). Secondary peripheral T-cell lymphoma in a patient with DLBCL harboring <i>BLM</i> mutation following CD19/CD22 bispecific CAR-T cell therapy. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2026-014873

Source records